Back to search

Tumor targeting properties of monoclonal antibodies with different affinity for target antigen CD44V6 in nude mice bearing head‐and‐neck cancer xenografts

Data up to Jan 2025

Published2002
Citations76
References33

Total Citations Per Year

Abstract

References (33)

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

1991 • 1,685 citations

CD44 and Its Interaction with Extracellular Matrix

1993 • 1,082 citations

High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.

2001 • 599 citations

CD44 variant exon epitopes in primary breast cancer and length of survival

1995 • 363 citations

A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier.

1990 • 343 citations

Prevention of tumor metastasis formation by anti-variant CD44.

1993 • 339 citations

CD44H regulates tumor cell migration on hyaluronate-coated substrate.

1992 • 334 citations

Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins

1994 • 319 citations

LFA-3, CD44, and CD45: Physiologic Triggers of Human Monocyte TNF and IL-1 Release

1990 • 300 citations

Human Immune Respone to Monoclonal Antibodies

1994 • 297 citations

Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies.

1998 • 234 citations

CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor

1995 • 230 citations

Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies.

1988 • 140 citations

Molecular Cloning and Expression of Human and Rat Tumor Necrosis Factor Receptor Chain (p60) and Its Soluble Derivative, Tumor Necrosis Factor-Binding Protein

1990 • 135 citations

Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugates.

1992 • 127 citations

The Core Protein of Epican, a Heparan Sulfate Proteoglycan on Keratinocytes, Is an Alternative Form of CD44

1992 • 78 citations

Characterization of a high-affinity monoclonal antibody specific for CD44v6 as candidate for immunotherapy of squamous cell carcinomas

1996 • 77 citations

Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients.

2000 • 73 citations

Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics.

1996 • 70 citations

Iodination of monoclonal antibodies for diagnosis and radiotherapy using a convenient one vial method.

1986 • 58 citations

Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer.

1995 • 52 citations

The Core Protein of Epican, a Heparan Sulfate Proteoglycan on Keratinocytes, Is an Alternative Form of CD44

1992 • 52 citations

Comparative dual label study of first and second generation antitumor-associated glycoprotein-72 monoclonal antibodies in colorectal cancer patients.

1993 • 50 citations

Comparisons between two monoclonal antibodies that bind to the same antigen but have differing affinities: uptake kinetics and 125I-antibody therapy efficacy in multicell spheroids.

1992 • 45 citations

Monoclonal antibody U36, a suitable candidate for clinical immunotherapy of squamous-cell carcinoma, recognizes a CD44 isoform

1996 • 42 citations

Comparison of the monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts

1996 • 32 citations

Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma.

1999 • 30 citations

Tumor Retention of 186Re-MAG3, 111In-DTPA and 125I Labeled Monoclonal Antibody G250 in Nude Mice with Renal Cell Carcinoma Xenografts

1998 • 29 citations

Immunotherapy with low and high affinity monoclonal antibodies 17-1A and 323/A3 in a nude mouse xenograft carcinoma model.

1995 • 28 citations

Rapid blood clearance of immunoglobulin G2a and immunoglobulin G2b in nude mice.

1991 • 28 citations

Comparison of the biodistribution and the efficacy of monoclonal antibody labeled with either 131I or 186Re in human ovarian cancer xenografts

1997 • 23 citations

CD44 Isoforms, Including the CD44 V3 Variant, Are Expressed on Endothelium, Suggesting a Role for CD44 in the Immobilization of Growth Factors and the Regulation of the Local Immune Response

1998 • 23 citations

Rapid elimination of mouse/human chimeric monoclonal antibodies in nude mice

1997 • 15 citations

Cited By (0)

Loading...
Tumor targeting properties of monoclonal antibodies with different affinity for target… (2002) – International Journal of Cancer | Metascience Observatory Explorer